US 10285952
Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
granted A61KA61K31/4709A61K35/17
Quick answer
US patent 10285952 (Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis) held by The Regents of the University of California expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4709, A61K35/17, A61K35/18, A61K35/19